• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS ENDURO FEMORAL COMPONENT CEMENTED F1L; KNEE ENDOPROSTHESES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS ENDURO FEMORAL COMPONENT CEMENTED F1L; KNEE ENDOPROSTHESES Back to Search Results
Model Number NB014Z
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Pain (1994)
Event Type  Injury  
Manufacturer Narrative
On 19mar2020 additional information was received and 2 complaints were created for the patient, referencing the left knee arthroplasties.(b)(4), 9610612-2020-00134.Associated medwatch-reports: right knee arthroplasties 9610612-2019-00912 ((b)(4) nb018z), 9610612-2019-00913 ((b)(4) nr865z), 9610612-2019-00914 ((b)(4) nr295z), 9610612-2019-00916 ((b)(4) nr400z), 9610612-2019-00915 ((b)(4) nr882z), 9610612-2019-00917 ((b)(4) nb012z), 9610612-2019-01011 ((b)(4) nr192z).Investigation on-going.Additional information / investigation results will be provided in a supplemental report.Right knee investigations ongoing, reported separately.A product safety case (psc) was opened.
 
Event Description
It was reported that there was an issue with enduro components.On (b)(6) 2014 the patient underwent a left total knee revision replacement; enduro implants were used and palacos cement.It was noted that a non-aesculap device was removed at that time.On (b)(6) 2015, the patient had left total knee arthroplasty (tka) for distal femoral peri-prosthetic fracture with loosening.The implants were replaced with enduro devices.Components were cemented one-on-one with tobramycin.On (b)(6) 2019, there was tibial and femoral loosening which required revision.A niobium-coated implant was used instead.Black staining of the tissues was noted.Additional treatments included stimulan pellets and vancomycin.Additional information has been requested.Associated medwatches: (b)(4), 9610612-2020-00134.The patient has also undergone multiple right knee revisions.
 
Manufacturer Narrative
Associated medwatch-reports: right left arthroplasties: (400469058) 9610612-2020-00133 (400469059) 9610612-2020-00134.Associated medwatch-reports: right knee arthroplasties 9610612-2019-00912 (b)(4).9610612-2019-00913 (b)(4).9610612-2019-00914 (b)(4).9610612-2019-00916 (b)(4).9610612-2019-00915 (b)(4).9610612-2019-00917 (b)(4).9610612-2019-01011 (b)(4).Updated investigation: (left knee).Failure description no product at hand, therefore a failure description is not possible.Batch history review the traceability of articles with batch management requirement is guaranteed by the production order number, which can be traced over the production period and the corresponding customer (backtrack).In addition, the raw materials, semi-finished parts, etc.Used for the order are documented in the manufacturing history records (dhr - device history records).This ensures the traceability of the internal supply and production chain.Internal traceability is thus guaranteed.Conclusion and root cause based on the information available it is not possible to determine a definitive root cause for the failure.At that time we do not consider that the mentioned failure is product related.Rationale until there are no valid results from a laboratory investigation regarding tissue samples with the mentioned black staining, it is not possible to determine the origin of the discoloration of the soft tissue.It is therefore not possible to determine a definitive root cause for the mentioned black staining.Corrective action a product safety case (psc) was opened.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS ENDURO FEMORAL COMPONENT CEMENTED F1L
Type of Device
KNEE ENDOPROSTHESES
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key9958860
MDR Text Key188675180
Report Number9610612-2020-00133
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
PMA/PMN Number
K101815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNB014Z
Device Catalogue NumberNB014Z
Was Device Available for Evaluation? No
Date Manufacturer Received04/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-